WHO ICTRP trial
The effects of nano-curcumin on obstructive pulmonary disease patients
IRCT20191222045853N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191222045853N1 |
|---|---|
| Public title | The effects of nano-curcumin on obstructive pulmonary disease patients |
| Scientific title | Investigating the effect of nano-curcumin supplementation on ventilatory capacity, polmonary function indices and serum interleukin-6 of patients with stage 3 (severe) and 4 (very severe) chronic obstructive pulmonary disease |
| Primary sponsor | Oroumia University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease, unspecified;J44.9 |
| Interventions | Intervention 1: Intervention group: nano-curcumin supplement, one capsule daily, each capsule contains 80 mg of curcumin in the form of nanomicelles, for 12 weeks, consumed with food, produced by Sina company. Intervention 2: Control group… |
| Registration date | Feb 6, 2020 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: